{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:29:26Z","timestamp":1788121766965,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008956","name":"National AIDS Control Organisation","doi-asserted-by":"publisher","award":["T-11020\/39\/2013-NACO"],"award-info":[{"award-number":["T-11020\/39\/2013-NACO"]}],"id":[{"id":"10.13039\/501100008956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.micpath.2020.104117","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T20:15:45Z","timestamp":1583180145000},"page":"104117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["High IL-5 levels possibly contributing to HIV viremia in virologic non-responders at one year after initiation of anti-retroviral therapy"],"prefix":"10.1016","volume":"143","author":[{"given":"Ashwini","family":"Shete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarali","family":"Kurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampada","family":"Dhayarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Ghate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikala","family":"Sangale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam","family":"Medhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobini","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Gangakhedkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104117_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/aid.2012.0266","article-title":"Performance of immunological response in predicting virological failure","volume":"29","author":"Ingole","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.micpath.2020.104117_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00042560-200206010-00004","article-title":"Discordant\" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy","volume":"30","author":"Wood","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.micpath.2020.104117_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia","volume":"344","author":"Deeks","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2020.104117_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dkl263","article-title":"Discordant immunological and virological responses to antiretroviral therapy","volume":"58","author":"Schechter","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2020.104117_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157340608783331443","article-title":"HIV protease inhibitors impact on apoptosis","volume":"4","author":"Rizza","year":"2008","journal-title":"Med. Chem."},{"key":"10.1016\/j.micpath.2020.104117_bib6","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1128\/JVI.76.21.11104-11112.2002","article-title":"Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults","volume":"76","author":"Barbour","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2020.104117_bib7","first-page":"979","article-title":"Multiple effects of the M184V resistance mutation in the reverse transcriptase of human immunodeficiency virus type 1","volume":"10","author":"Turner","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib8","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/JCM.41.7.3007-3012.2003","article-title":"High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis","volume":"41","author":"Nicastri","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl 2","key":"10.1016\/j.micpath.2020.104117_bib9","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/313855","article-title":"Determinants of virological response to antiretroviral therapy: implications for long-term strategies","volume":"30","author":"Deeks","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104117_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1752-0509-7-11","article-title":"A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns","volume":"7","author":"Bershteyn","year":"2013","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.micpath.2020.104117_bib11","article-title":"Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India","volume":"95","author":"Karade","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.micpath.2020.104117_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2019.01.017","article-title":"Incomplete functional T-cell reconstitution in immunological non-responders at one year after initiation of antiretroviral therapy possibly predisposes them to infectious diseases","volume":"81","author":"Shete","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104117_bib13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/QAD.0b013e32833c703e","article-title":"Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells\/microl is associated with improved treatment outcomes in South Africa","volume":"24","author":"Fox","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2020.104117_bib14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1099\/0022-1317-83-5-1183","article-title":"Co-expression of interleukin-5 influences replication of simian\/human immunodeficiency viruses in vivo","volume":"83","author":"Kozyrev","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micpath.2020.104117_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2183\/pjab.87.463","article-title":"Interleukin-5 and IL-5 receptor in health and diseases","volume":"87","author":"Takatsu","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.micpath.2020.104117_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0952-7915(01)00284-9","article-title":"Eosinophils, allergy and parasites","volume":"13","author":"Dombrowicz","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib17","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/j.ijid.2013.03.022","article-title":"Deworming of intestinal helminths reduces HIV-1 subtype C viremia in chronically co-infected individuals","volume":"17","author":"Mulu","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104117_bib18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/QAD.0b013e32830a502e","article-title":"Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Walson","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2020.104117_bib19","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1073\/pnas.1015476108","article-title":"TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A\/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection","volume":"108","author":"Fei","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2020.104117_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1995-7645(10)60070-3","article-title":"Serum cytokines profiles in Nigerian children with Ascaris lumbricoides infection","volume":"3","author":"Goddey Nop","year":"2010","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.micpath.2020.104117_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000095997","article-title":"Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposure","volume":"142","author":"Fitzsimmons","year":"2007","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib22","first-page":"78","article-title":"Nonimmunoglobulin e-mediated immune reactions to foods","volume":"2","author":"Spergel","year":"2006","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-3083.2009.02345.x","article-title":"Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths","volume":"71","author":"Rosso","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib24","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2011-12-396101","article-title":"IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity","volume":"119","author":"Tran","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2020.104117_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0165-5728(02)00320-X","article-title":"Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA","volume":"134","author":"Luder","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.micpath.2020.104117_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10875-014-0115-3","article-title":"A defective oxidative burst and impaired antigen presentation are hallmarks of human visceral leishmaniasis","volume":"35","author":"Roy","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib27","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.4049\/jimmunol.167.6.3207","article-title":"Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus","volume":"167","author":"Schonemeyer","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2020.104117_bib28","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1128\/IAI.69.12.7380-7386.2001","article-title":"Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response","volume":"69","author":"Dainichi","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2020.104117_bib29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/648444","article-title":"Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa","volume":"49","author":"Hoffmann","year":"2009","journal-title":"Clin. Infect. Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401019321564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401019321564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:22:34Z","timestamp":1778545354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401019321564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":29,"alternative-id":["S0882401019321564"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104117","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High IL-5 levels possibly contributing to HIV viremia in virologic non-responders at one year after initiation of anti-retroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104117"}}